Masterflex

According to a voting-rights notification dated 13 August 2026, Alpha Entrepreneurial Partners Investment-AG held 687,296 shares of Masterflex SE, thereby reaching a voting-rights stake of 7.05%. No additional instruments were reported. The notification was made pursuant to §40 Abs.1 WpHG for dissemination Europe-wide. » Más en de.investing.com

Masterflex achieved sales of €54.30m in H1 2026 (+1.7%), an operating EBIT of €8m and a net profit of €5.30m (earnings per share €0.55). Growth was driven mainly by the medical technology and food industry segments within the Life division; the material cost ratio and other operating expenses also improved. Higher personnel costs due to the build-up at the Morocco site and inflation partly dampened earnings. Masterflex confirms its full-year guidance of €103–108m in sales and expects an EBIT of €13–16m, although start-up costs in Morocco are likely to slightly weigh on 2026 results. » Más en de.investing.com

A major shareholder states that its indirect voting interest in Masterflex SE was 29.37% on 13 July 2026. The investment serves strategic objectives; further purchases are possible, but the 30% threshold should not be exceeded for now. The investor currently supports the management board and supervisory board, but does not rule out possible representation on the supervisory board in the medium term; the funds come from own resources. » Más en de.investing.com